Skip to main
NTRA

Natera (NTRA) Stock Forecast & Price Target

Natera (NTRA) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Natera is financially stable with a current ratio of 2.63 and a debt-to-equity ratio of 0.60, showing their ability to meet short-term obligations and their conservative financial structure. With a strong focus on research and development, Natera is continuously expanding its product offerings and reaching new markets, making it a promising investment for the future.

Bears say

Natera is expected to experience rapid growth in its Signatera MRD business, which, along with additional growth from its Latitude and Foresight products, is likely to have a major impact on the company's stock. However, there are concerns about increasing competition in the MRD market, particularly from other well-funded players, and persistent competitive intensity in the Women's Health market. Additionally, there are risks associated with Natera's aggressive investments in new market opportunities, such as pediatricians and newborn screening, which could potentially strain the company's financials and put pressure on its stock.

Natera (NTRA) has been analyzed by 18 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Natera and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Natera (NTRA) Forecast

Analysts have given Natera (NTRA) a Buy based on their latest research and market trends.

According to 18 analysts, Natera (NTRA) has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $314.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $314.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Natera (NTRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.